TITLE

Once-daily Tadalafil for ED: Efficacy and Safety

AUTHOR(S)
Kuritzky, Louis
PUB. DATE
September 2013
SOURCE
Clinical Cardiology Alert;Sep2013 Clinical Briefs, p17
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the study of A. D. Seftel and colleagues regarding the efficacy and safety of taking 2.5-10.0 milligrams per day of tadalafil (TAD-QD) for men who suffer from erectile dysfunction (ED).
ACCESSION #
90216963

 

Related Articles

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Infectious Disease Alert;Sep2013 Clinical Briefs, p17 

    The article discusses research done on the efficacy and safety of once-daily tadalafil for erectile dysfunction by A. D. Seftel, published in the 2013 issue of the "International Journal of Impotence Research."

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Clinical Oncology Alert;Sep2013 Clincal Briefs, p17 

    The article discusses the study of A. D. Seftel and colleagues regarding the efficacy and safety of daily doses of tadalafil (TAD-QD) in men who suffer from mild-moderate erectile dysfunction (ED).

  • Efficacy of Tadalafil De-Escalation in the Treatment of Psychogenic Erectile Dysfunction. Li, Guangyu; Lan, Haiyan; Liang, Jihong; Zhang, Chengmei; Huang, Cunchao // Urologia Internationalis;Mar2017, Vol. 98 Issue 2, p205 

    Objectives: To assess the efficacy of tadalafil de-escalation in the therapeutic effects of psychogenic erectile dysfunction (ED) during the 3 months extension phase. Methods: A total of 90 men with mild to severe psychogenic ED were randomly divided into 2 groups: tadalafil 5 mg group and...

  • Once-daily Tadalafil for ED: Efficacy and Safety. Kuritzky, Louis // Internal Medicine Alert;8/15/2013, Vol. 35 Issue 15, p119 

    The article presents brief information on a study led by A.D. Seftel and colleagues on the therapeutic use of Tadalafil (TAD-QD) among men with erectile dysfunction.

  • Sequential Chemotherapies for Advanced Gastric Cancer: A Retrospective Analysis of 111 Patients. Elsing, Christoph; Herrmann, Christina; Hannig, Carla Verena; Stremmel, Wolfgang; Jäger, Dirk; Herrmann, Thomas // Oncology;Nov2013, Vol. 85 Issue 5, p262 

    Background: The role of second-line chemotherapy in advanced gastric cancer is not yet fully established. Patients and Methods: We analysed 111 patients with advanced gastric cancer treated at the University Hospital Heidelberg (51) and the private oncology practice Bottrop/Dorsten (60) between...

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // OB/GYN Clinical Alert;Sep2013 Clincal Briefs, p17 

    The article focuses on a study related to the safety and efficacy of once daily tadalafil (TAD-QD) in doses ranging from 2.5-10.0 miligram per day and also highlights that TAD-QD has more than doubled the rates of successful intercourse.

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Neurology Alert;Sep2013 Clinical Briefs, p17 

    The article discusses research on the efficacy and safety of tadalafil in restoring sexual function in men, which was conducted by A.D. Seftel and colleagues and published in the 2013 issue of the "International Journal of Impotence Research."

  • Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9). Esposito, Francesca; Cecere, Sabrina Chiara; Magazzino, Francescapaola; Katsaros, Dionyssios; Ottaiano, Alessandro; Gadducci, Angiolo; Pisano, Carmela; Scalone, Simona; Rabaiotti, Emanuela; Salutari, Vanda; Cormio, Gennaro; Canuto, Emilie Marion; Greggi, Stefano; Savarese, Antonella; Marinaccio, Marco; Scollo, Paolo; Santeufemia, Davide Adriano; Sacco, Cosimo; Facchini, Gaetano; Pignata, Sandro // Oncology;Jul2014, Vol. 86 Issue 5/6, p351 

    Background and Aims: Ovarian clear cell carcinoma (CCC) has a poorer prognosis than other subtypes of ovarian cancer. In this study, we evaluated the responsiveness to second-line chemotherapy in recurrent ovarian CCC. Methods: The MITO-9 project investigated a cohort of patients observed...

  • Initially Localized Synovial Sarcoma in Adults: A Retrospective Single-Center Analysis of 26 Patients Registered at the Department of Oncology, University of Vienna between 2004 and 2013. Lamm, Wolfgang; Schur, Sophie; Köstler, Wolfgang J.; Amann, Gabriele; Pokrajac, Boris; Funovics, Philipp; Panotopoulos, Joannis; Brodowicz, Thomas // Oncology;Jul2014, Vol. 87 Issue 1, p48 

    Background: Synovial sarcoma is a rare subgroup of all soft-tissue sarcomas. The aim of this retrospective single-center analysis was to investigate the outcome of patients with initially localized disease. Patients and Methods: Twenty-six patients were enrolled in this retrospective...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics